Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System
Open Access
- 30 November 2020
- Vol. 12 (12), 1367
- https://doi.org/10.3390/v12121367
Abstract
SARS-CoV-2 infection is mediated by the binding of its spike protein to the angiotensin-converting enzyme 2 (ACE2), which plays a pivotal role in the renin-angiotensin system (RAS). The study of RAS dysregulation due to SARS-CoV-2 infection is fundamentally important for a better understanding of the pathogenic mechanisms and risk factors associated with COVID-19 coronavirus disease and to design effective therapeutic strategies. In this context, we developed a mathematical model of RAS based on data regarding protein and peptide concentrations; the model was tested on clinical data from healthy normotensive and hypertensive individuals. We used our model to analyze the impact of SARS-CoV-2 infection on RAS, which we modeled through a downregulation of ACE2 as a function of viral load. We also used it to predict the effect of RAS-targeting drugs, such as RAS-blockers, human recombinant ACE2, and angiotensin 1–7 peptide, on COVID-19 patients; the model predicted an improvement of the clinical outcome for some drugs and a worsening for others. Our model and its predictions constitute a valuable framework for in silico testing of hypotheses about the COVID-19 pathogenic mechanisms and the effect of drugs aiming to restore RAS functionality.Keywords
This publication has 79 references indexed in Scilit:
- Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosisRespiratory Research, 2010
- Sex differences in circulating and renal angiotensins of hypertensive mRen().Lewis but not normotensive Lewis ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney DiseasePharmacological Reviews, 2007
- Novel sandwich ELISA for human angiotensinogenAmerican Journal of Physiology-Renal Physiology, 2007
- Systematic Review of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blockade in HypertensionHypertension, 2005
- Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)Hypertension, 2002
- Role of the Renin-Angiotensin System in Vascular DiseasesHypertension, 2001
- The Acute Respiratory Distress SyndromeNew England Journal of Medicine, 2000
- Angiotensin II Receptor Blockade in Normotensive SubjectsHypertension, 1999
- Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma.Hypertension, 1986